Qube Research & Technologies LTD Kamada LTD Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Kamada LTD stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1 shares of KMDA stock, worth $5. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 1
-0.0%
Holding current value
$5
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KMDA
# of Institutions
35Shares Held
6.37MCall Options Held
2.2KPut Options Held
63.8K-
Phoenix Holdings Ltd. Givatayim, L31.83MShares$9.99 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$7.76 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny836KShares$4.56 Million0.01% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3726KShares$3.96 Million0.37% of portfolio
-
Wells Fargo & Company San Francisco, CA638KShares$3.48 Million0.0% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $244M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...